Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-050210
Filing Date
2013-09-23
Accepted
2013-09-23 15:22:02
Documents
1
Period of Report
2013-09-12

Document Format Files

Seq Description Document Type Size
1 SHARES ISSUED WITH ACQUSITION OF MP rrd391093.html 4  
1 SHARES ISSUED WITH ACQUSITION OF MP rrd391093.xml 4 3439
  Complete submission text file 0001181431-13-050210.txt   4815
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Issuer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address
Patel Nikin (Reporting) CIK: 0001587273 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10352 | Film No.: 131110059